Applied UV, Inc. (AUVPQ)

Applied UV, Inc.: A Comprehensive Overview

Company Profile:

History: Founded in 2013, Applied UV, Inc. (AUVI) is a pathogen elimination and infection control technology company with a focus on the healthcare, commercial, and consumer markets.

Core Business Areas:

• Healthcare: AUVI provides disinfection and air purification solutions for hospitals, clinics, and other healthcare facilities.
• Commercial: AUVI offers air and surface disinfection solutions for businesses such as hotels, restaurants, and schools.
• Consumer: AUVI sells air and water purification products for individual homes.

Leadership Team:

• Max Munn: Co-founder and Chief Executive Officer
• James Malmros: President and Chief Operating Officer
• Steve Kesten: Chief Financial Officer

Corporate Structure: AUVI is a publicly traded company headquartered in Port Jefferson Station, New York.

Top Products and Market Share:

Top Products:

• Airocide® Air Purifier: An air purification system that utilizes short-wavelength ultraviolet (UV) light to kill pathogens in the air.
• Sterilumen™ Disinfection System: A mobile air disinfection unit with a high-output UV lamp for rapid surface decontamination.
• Cleansepoint™ Surface Cleaning Device: A handheld device that utilizes a 254nm UV lamp to disinfect surfaces.

Market Share: AUVI is a relatively small player in the air and surface disinfection market, with a market share estimated to be less than 1%. However, the company is experiencing strong growth, particularly in the healthcare sector.

Product Performance and Market Reception:

AUVI's products have been well-received by customers and reviewers, with positive feedback on their effectiveness and ease of use. The company has also received several industry awards for its innovation and technology.

Total Addressable Market:

The global market for air and surface disinfection is estimated to be worth over $12 billion, and it is expected to grow at a healthy rate in the coming years due to increasing awareness of the importance of infection control.

Financial Performance:

Revenue and Profitability: AUVI's revenue has grown significantly in recent years, reaching $4.2 million in 2022. However, the company is not yet profitable, reporting a net loss of $7.3 million in 2022.

Margins: AUVI has low gross margins, but its operating expenses are also relatively low, resulting in a moderate operating margin.

Earnings per Share (EPS): AUVI does not currently have positive EPS.

Year-over-Year Comparisons: AUVI's revenue and gross margins have increased year-over-year, but the company's losses have also widened.

Cash Flow and Balance Sheet Health: AUVI's cash flow from operations is negative, and the company has a relatively small amount of cash on hand.

Dividends and Shareholder Returns: AUVI does not currently pay a dividend. Overall shareholder returns have been negative since the company's IPO in 2021.

Growth Trajectory:

Historical Growth: AUVI has experienced strong revenue growth in recent years.

Future Projections: The company expects to continue growing its revenue at a rapid pace in the coming years. AUVI's future growth will be driven by increased sales of its current products, as well as the launch of new products.

Recent Initiatives: AUVI is focused on expanding its product portfolio and entering new markets. The company is also investing in research and development to improve the efficacy of its products.

Market Dynamics:

Industry Trends: The air and surface disinfection market is growing rapidly due to several factors, including increased awareness of the importance of infection control, the rise of antibiotic-resistant bacteria, and the growing demand for healthier indoor environments.

Technology Advancements: Technological advancements are constantly improving the effectiveness of air and surface disinfection products. The use of UV light, ozone, and other technologies is increasing the demand for these products.

Competitive Landscape:

Major Competitors:

• Sterilance: A major player in the healthcare disinfection market.
• Xenex Disinfection Services: A leading provider of UV disinfection services.
• Halio: A developer of air and surface disinfection products using ozone technology.

Market Share Comparisons: AUVI's main competitors have significantly larger market share than AUVI. Sterilance leads the healthcare disinfection market with a market share of around 10%, while Xenex holds a market share of approximately 7%.

Competitive Advantages: AUVI's competitive advantages include its innovative technology, its focus on customer service, and its relatively low-cost products.

Challenges and Opportunities:

Challenges:

• Competition: AUVI faces intense competition from established players in the market.
• Profitability: The company is not yet profitable and needs to demonstrate its ability to generate sustained profits.
• Scaling Up: AUVI needs to scale up its operations to meet the growing demand for its products.

Opportunities:

• Growing Market: The air and surface disinfection market is growing rapidly, providing AUVI with a significant opportunity for expansion.
• Product Innovation: AUVI is continuously developing new and improved products, which could give it a competitive edge.
• Partnerships: AUVI could form strategic partnerships with other companies to expand its reach and market share.

Recent Acquisitions:

• 2022: Acquired Aura Air, a manufacturer of air purifiers for homes and offices.
• 2021: Acquired ActivePure Technology, a provider of air and surface disinfection solutions for businesses and consumers.

AI-Based Fundamental Rating:

Overall Rating: 7/10

Justification: AUVI has a strong growth trajectory and operates in a large and growing market. However, the company is not yet profitable and faces intense competition.

Disclaimer:

The information provided in this overview is based on publicly available data and should not be considered investment advice. It is important to conduct your own research before making any investment decisions.

Sources:

• Applied UV, Inc. website
• SEC filings
• Market research reports
• Industry news articles